A practitioner's 10-year experience with isotretinoin and side effect profiles

International Journal of Cosmetic Surgery and Aesthetic Dermatology

Volumn 4, Issue 2, 2002, Pages 89-94

  Sadick, Neil S ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHOLESTEROL; CORTICOSTEROID DERIVATIVE; EMOLLIENT AGENT; EYE DROPS; ISOTRETINOIN; LACTATE DEHYDROGENASE; LIVER ENZYME; SODIUM CHLORIDE; TRIACYLGLYCEROL;

ACNE CYSTICA; ADOLESCENT; ADULT; AFFECTIVE NEUROSIS; AGED; AMBULATORY CARE; APPETITE DISORDER; ARTICLE; ASTHMA; BLOOD CELL COUNT; BLOOD CHEMISTRY; BLOOD SAMPLING; CARDIOVASCULAR RISK; CENTRAL NERVOUS SYSTEM DISEASE; CHEILITIS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CONSULTATION; DEPRESSION; DIET THERAPY; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG MONITORING; DRUG WITHDRAWAL; EXPERIENCE; EYE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HEMATURIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LABORATORY TEST; LIVER DISEASE; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MENSTRUAL IRREGULARITY; MOUTH DISEASE; MUCOSA; MUSCULOSKELETAL DISEASE; PHYSICIAN; PREGNANCY TEST; RECURRENT DISEASE; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN DISEASE; SKIN NODULE; TERATOGENICITY; THORAX PAIN; TRIACYLGLYCEROL BLOOD LEVEL; UTERINE CERVIX DISEASE; VISUAL IMPAIRMENT; WEIGHT REDUCTION; WOUND HEALING IMPAIRMENT;

EID: 0036621813     PISSN: 15308200     EISSN: None     Source Type: Journal    
DOI: 10.1089/153082002760331072     Document Type: Article

References (15)

1. Agris, J.: A new syndrome: Isotretinoin (Accutane) malformation. Am J Cosmet Dermatol 1989;(3):183-185.
2. Layton, A.M., Knagg, H., Taylor, J., and Cunliffe, W.J.: Isotretinoin for acne vulgaris - 10 years later: a safe and successful treatment. Br J Dermatol 1993;129:292-296.
3. Peck, G.L., Olsen, T.G., Butkus, D., Pandya, M., Arnaud-Battandier, J., Gross, E.G., Windhorst, D.B., and Cheripko, J.: Isotretinoin versus placebo in the treatment of cystic acne. J Am Acad Dermatol 1982;6:735-745.
4. Leyden, J.J.: The role of isotretinoin in the treatment of acne: personal observations. J Am Acad Dermatol 1998;39:S45-S49.
5. Saurat, J.H.: Side effects of systemic retinoids and their clinical management. J Am Acad Dermatol 1992;27:S23-S28.
6. Vahlquist, A.: Long-term safety of retinoid therapy. J Am Acad Dermatol 1992;27:S29-S33.
7. Bigby, M., and Stern, R.S.: Adverse reactions to isotretinoin. A report from the Adverse Drug Reaction Reporting System. J Am Acad Dermatol 1988;18:543-552.
8. Lestringant, G.G., Frossard, P.M., Agarwal, M., and Galadari, I.H.: Variations in lipid and lipoprotein levels during isotretinoin treatment for acne vulgaris with special emphasis on HDL-cholesterol. Int J Dermatol 1997;36:859-862.
9. Stainforth, J.M., Layton, A.M., Taylor, J.P., and Cunliffe, W.J.: Isotretinoin for the treatment of acne vulgaris: which factors may predict the need for more than one course? Br J Dermatol 1993;129:297-301.
10. Goulden, V., Layton, A.M., Cunliffe, W.J.: Long-term safety of isotretinoin as a treatment for acne vulgaris. Br J Dermatol 1994;131:360-363.
11. Margolis, D.J., Attie, M., and Leyden, J.J.: Effects of isotretinoin on bone mineralization during routine therapy with isotretinoin for acne vulgaris. Arch Dermatol 1996;132:769-774.
12. Ostlere, L.S., Harris, D., Morse-Fisher, N., and Wright, S.: Effect of systemic administration of isotretinoin on blood lipids and fatty acids in acne patients. Int J Dermatol 1996;35:216-218.
13. Georgala, S., Schulpis, K.H., Potouridou, I., and Papadogeorgaki, H.: Effects of isotretinoin therapy on lipoprotein (a) serum levels. Int J Dermatol 1997;36:863-864.
14. Barth, J.H., Macdonald-Hull, S.P., Mark, J., Jones, R.G., and Cunliffe, W.J.: Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests. Br J Dermatol 1993;129:704-707.
15. Leachman, S.A., Insogna, K.L., Katz, L., Ellison, A., and Milstone, L.M.: Bone densities in patients receiving isotretinoin for cystic acne. Arch Dermatol 1999;135:961-965.